Elder Pharmaceuticals shines on completing sale of domestic formulations business

30 Jun 2014 Evaluate

Elder Pharmaceuticals is currently trading at Rs. 218.35, up by 5.95 points or 2.80% from its previous closing of Rs. 212.40 on the BSE.

The scrip opened at Rs. 215.90 and has touched a high and low of Rs. 223.00 and Rs. 214.10 respectively. So far 52955 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 380.00 on 05-Jul-2013 and a 52 week low of Rs. 188.00 on 04-Feb-2014.

Last one week high and low of the scrip stood at Rs. 223.00 and Rs. 210.15 respectively. The current market cap of the company is Rs. 449.76 crore.

The promoters holding in the company stood at 24.83% while Institutions and Non-Institutions held 30.53% and 44.64% respectively.

Elder Pharmaceuticals has completed the transaction for sale and transfer of its branded domestic formulations business in India and Nepal to Torrent Pharmaceuticals on a slump sale basis on June 29, 2014. This transaction was in pursuance of the Business Transfer Agreement (BTA) entered into between the company and Torrent on December 13, 2013.

Elder Pharmaceuticals (EPL) has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.